These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 820068)

  • 1. Growth hormone in the blood of patients after administration of synthetic thyrotropin releasing hormone.
    Nedvídková J; Felt VI
    Vnitr Lek; 1976 May; 22(5):453-6. PubMed ID: 820068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Triiodothyronine and thyroxine in the blood of patients with thyroid diseases after oral administration of thyrotropin releasing hormone (TRH)].
    Nedvídková J; Felt V
    Vnitr Lek; 1976 May; 22(5):457-60. PubMed ID: 820069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Response of the thyrotropic hormone after oral administration of thyrotropin releasing hormone in patients with disorders of the thyroid gland].
    Nedvídková J; Felt V
    Vnitr Lek; 1976 Mar; 22(3):278-82. PubMed ID: 817509
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of thyreoliberin VUFB in the diagnosis of acromegaly (author's transl)].
    Felt V; Nedvídková J; Shameti H; Kasafírek E
    Cas Lek Cesk; 1979 Feb; 118(8):232-4. PubMed ID: 109212
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of synthetic thyrotropin-releasing hormone on plasma thyrotropin, growth hormone and insulin levels in man.
    Saito S; Abe K; Yoshida H; Kaneko T; Nakamura E
    Endocrinol Jpn; 1971 Feb; 17(6):101-8. PubMed ID: 4104660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of thyrotropin releasing hormone (TRH) in normal subjects and in patients with thyroid gland diseases].
    Lauridsen UB; Friis T; Kirkegaard C; Hansen JM; Siersbaek-Nielsen K
    Ugeskr Laeger; 1974 Jun; 136(25):1360-4. PubMed ID: 4210165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of the peroral TRH test in the diagnosis of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1977 Sep; 23(9):865-7. PubMed ID: 411251
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 11. [An oral test using thyrotropin releasing hormone in the diagnosis of the thyroid diseases].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1977 Jun; 116(24):740-2. PubMed ID: 407001
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spontaneous diurnal variations as well as the effect of TRH, MIH and LH-RH on growth hormone secretion in active acromegaly].
    Heesen D; Hadam W; Mies R; Schorn H; Winkelmann W
    Verh Dtsch Ges Inn Med; 1975; 81():1521-3. PubMed ID: 5831
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth hormone liberation after TRH in patients with acromegaly].
    Morosini PP; Campanella N; Carletti P; Sturbini S; Testa I
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1239-42. PubMed ID: 6779828
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
    Maeda K
    Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 18. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Further findings on the action of synthetic thyrotropin releasing hormone on the TSH serum level in various endocrine diseases].
    Wagner H; Böckel K; Grote G; Hrubesch M; Vosberg H; Junge-Hülsing G; Hauss WH
    Med Welt; 1972 Oct; 23(41):1419-21. PubMed ID: 4628828
    [No Abstract]   [Full Text] [Related]  

  • 20. [TSH-level in the sera of healthy subjects and patients with thyroid function disorders before and following intravenous injection of synthetic thyrotropin-releasing hormone].
    Wagner H; Hrubesch M; Böckel K; Vosberg H; Junge-Hülsing G
    Med Welt; 1971 Nov; 47():1883-4. PubMed ID: 5002884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.